Finance

Lists
Why is 51S down 15,38%?
Dive Deeper
51S:FRA
Cynata Therapeutics Ltd
0,0055 €
-15,38%
(-0,0010) 1D
14 қаз., 08:03:02 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 51S...
Open
0,01 €
High
0,01 €
Low
0,01 €
Mkt. cap
4,79 млн
Avg. vol.
0,00
Volume
0,00
52-wk high
0,24 €
52-wk low
0,00 €
No. of employees
0
Open
0,01 €
High
0,01 €
Low
0,01 €
Mkt. cap
4,79 млн
Avg. vol.
0,00
Volume
0,00
52-wk high
0,24 €
52-wk low
0,00 €
No. of employees
0
News stories
From web sources and news partners
About Cynata Therapeutics Ltd
CEORoss Alexander Macdonald
Employees0
Founded2003
Headquarters-
Sector-
Websitecynata.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
855,81 м.
855,81 м.
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
2,77 млн
2,77 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,69 млн
1,69 млн
-763,69 м.
-763,69 м.
Operating expense
2,22 млн
2,22 млн
2,63 млн
2,63 млн
Total operating expenses
2,22 млн
2,22 млн
2,63 млн
2,63 млн
Operating income
-1,36 млн
-1,36 млн
-2,63 млн
-2,63 млн
Other non operating income
-
-
-
-
EBT including unusual items
-1,33 млн
-1,33 млн
-3,29 млн
-3,29 млн
EBT excluding unusual items
-1,33 млн
-1,33 млн
-2,62 млн
-2,62 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
425,31 м.
425,31 м.
527,43 м.
527,43 м.
Net income
-1,33 млн
-1,33 млн
-3,29 млн
-3,29 млн
Net profit margin
-155,55%
-155,55%
-
-
Earnings per share
-
-
-
-
Interest and investment income
30,33 мың
30,33 мың
9,42 мың
9,42 мың
Interest expense
-
-
-
-
Net interest expenses
30,33 мың
30,33 мың
9,42 мың
9,42 мың
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,30 млн
-1,30 млн
-2,56 млн
-2,56 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары